Radioactive cancer fighter enters first human trials
Disease control
Recruiting now
This early-stage study is testing a new radioactive drug called 225Ac-ABD147 for people with two aggressive types of lung cancer that have progressed after standard chemotherapy. Researchers will first determine safe doses and track where the drug goes in the body, then evaluate …
Phase: PHASE1 • Sponsor: Abdera Therapeutics Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC